Literature DB >> 22039258

Blood consult: treating del(5q) myelodysplastic syndromes.

Sudipto Mukherjee1, Ramon V Tiu, Mikkael A Sekeres.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22039258     DOI： 10.1182/blood-2011-09-376103

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  1 in total

1.  Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q).

Authors:  Aleksandra Butrym; Ewa Lech-Maranda; Elżbieta Patkowska; Beata Kumiega; Maria Bieniaszewska; Andrzej Mital; Krzysztof Madry; Tigran Torosian; Ryszard Wichary; Justyna Rybka; Krzysztof Warzocha; Grzegorz Mazur
Journal:  BMC Cancer       Date:  2015-07-08       Impact factor: 4.430
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.